BioCryst Pharmaceuticals
BCRX
BCRX
75 hedge funds and large institutions have $264M invested in BioCryst Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 73 → 75 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
75
Holding in Top 10
2
Calls
$6.94M
Puts
$3.7M
Top Buyers
| 1 | +$19.6M | |
| 2 | +$16.4M | |
| 3 | +$12.3M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.22M |
| 5 |
Morgan Stanley
New York
|
+$3.48M |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$5.8M | |
| 3 | -$5.43M | |
| 4 |
VM
VHCP Management
New York
|
-$3.24M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$2.81M |